M6P Therapeutics
Pre-clinicalM6PT is focused on developing next generation enzyme replacement and gene therapies for LSDs.
Founded
2018
Focus
Small Molecules
About
M6PT is focused on developing next generation enzyme replacement and gene therapies for LSDs.
Funding History
2Total raised: $163M
Series B$116MNovo HoldingsJun 15, 2022
Series A$47MNovo HoldingsOct 15, 2020
Company Info
TypePrivate
Founded2018
LocationSt. Louis, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile